Navigation Links
Detailed Cholesterol Test Provides Vital Clues for Women in Search of PCOS Answers
Date:9/9/2010

BIRMINGHAM, Ala., Sept. 9 /PRNewswire/ -- Polycystic Ovarian Syndrome, known as PCOS, is a silent and often mysterious disease that plays havoc with a woman's body and increases the risk of serious illness.

PCOS is the number one cause of female infertility and increases the risk of heart disease, insulin resistance, diabetes and certain cancers. It is also the most common metabolic abnormality in women of child bearing age, affecting 5 to 10 million women nationwide, according to the American Association of  Clinical Endocrinologists. Yet, it is plagued by a lack of awareness and is one of the most difficult diseases to diagnose.

There is no single test for diagnosing the illness, but a detailed cholesterol profile called the VAP Cholesterol Test, along with diet, exercise and the right medication, is changing how doctors approach PCOS and is dramatically altering patients' lives for the better.

"The average patient sees five medical practitioners before getting diagnosed," said Steven Foley, M.D., a Colorado Springs, Colo., gynecologist who specializes in the identification and treatment of patients suffering from PCOS. "That's because the symptoms can vary from woman to woman. Early diagnosis is critical not only in reducing the risk of more serious complications, but because PCOS can be devastating for women physically and emotionally."

Women often spend a tremendous about of time and money searching for answers to these unexplained symptoms and for a doctor who understands the complexities of PCOS. Foley recently used the VAP Test to help diagnose PCOS in a 24-year-old patient who was struggling with weight gain, insulin resistance and high cholesterol levels. The Colorado Springs woman faced the prospect of early heart disease, diabetes and infertility unless her health improved. Foley prescribed a healthy diet, regular exercise and a diabetes medicine that helps to control her insulin and blood sugar levels. He continues to use the VAP Test to manage the woman's PCOS and heart disease risk.

"It is the most accurate and easiest method to evaluate my female patients for elevated cholesterol as well as polycystic ovarian syndrome," Foley said. "It is particularly valuable when developing a treatment plan for women and also helps to monitor response to treatment."

September is PCOS Awareness Month and serves as a reminder for women to have a conversation with their health care provider about PCOS. The four major symptoms of PCOS are irregular periods, weight gain, high testosterone levels and metabolic disorders, including cholesterol problems.

Developed by Atherotech Diagnostics Lab (www.atherotech.com), the VAP Test plays a central role in the diagnosis of PCOS because, unlike the standard cholesterol test, it measures a range of cholesterol subclasses and can be administered without fasting. The VAP Test is widely covered by insurance, and results have shown a correlation between patients who have PCOS and low levels of HDL2, a highly protective subclass of high density lipoprotein (HDL).

Atherotech Diagnostics Lab has seen steadily increasing demand from gynecologists and endocrinologists for the VAP Cholesterol Test. The VAP Test is available nationwide and reports 22 separate components of blood compared to just four in the standard cholesterol test (LDL, HDL, total cholesterol and triglycerides) at no additional cost. For more information call 877.901.8510 or visit www.atherotech.com.

About Atherotech Diagnostics Lab

Atherotech is a CLIA-certified clinical reference laboratory and cardiodiagnostic company focusing on cardiometabolic tests, including the company's patented VAP Cholesterol Test, which reports the cholesterol content of all lipids, components and subclasses. The VAP Test is the first cholesterol profile to comply with updated National Cholesterol Education Program ATP III recommendations for direct LDL measurement, which is accurate with non-fasting samples. The VAP Test is available through national and regional diagnostic laboratories and is reimbursed by many of the largest private insurers as well as Medicare. For more information, visit www.atherotech.com.


'/>"/>
SOURCE Atherotech Diagnostics Lab
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MedQuist Performance Monitor Offers Transparency, Detailed Reporting and Measurement of Clinical Documentation Metrics
2. People at Intermediate Risk of Heart Disease With Elevated hsCRP Benefit From Statin Therapy Even if Cholesterol Levels are Normal
3. Amsterdam Molecular Therapeutics Reports Promising Data From Cholesterol Lowering Gene Therapy Study
4. New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes
5. Mylan Confirms First-to-File Patent Challenge Relating to Vytorin(R) Cholesterol Medication
6. New Data: Cholesterol Management Analysis of Upsher-Smiths Slo-Niacin(R) Tablets in Combination with Lipitor(R)
7. New Web Sites Educate About Triglycerides and HDL Cholesterol
8. Atherotech to Exhibit VAP(R) Cholesterol Test at American Heart Association Scientific Sessions 2009
9. U.S. Food and Drug Administration Approves CRESTOR(R) for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
10. New Data for Abbotts TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management
11. New Study Suggests Cholesterol-Lowering Statins Reduce Severe Asthma Attacks that Result in Hospitalizations and Emergency Room Visits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Research and Markets has announced the ... report to their offering. ... favourable commercial environment for MedImmune to enter. The US ageing ... serve to drive considerable growth for effective anti-influenza medications. The ... sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... RIDGE, Ill. and INDIANAPOLIS ... of students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship ... The 2016 scholarship winners, announced today online at ... to let type 1 diabetes stand in the way ... Diabetes has supported the Foundation,s scholarship program since 2012, ...
(Date:6/23/2016)... N.J. , June 23, 2016  Guerbet announced ... Premier Inc.,s Supplier Horizon Award . ... year, Guerbet was recognized for its support of Premier ... creation through clinical excellence, and commitment to lower costs. ... to receive this recognition of our outstanding customer service ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
Breaking Medicine News(10 mins):